This is the #1 first-line oral medication for T2D, found in nearly every diabetes treatment guideline.
Metformin
This term describes blood sugar levels that are too high.
Hyperglycemia
This lifestyle factor, along with physical inactivity, is the #1 modifiable risk factor for developing T2D
Obesity
This cell in the pancreas is responsible for producing insulin
Beta cells
This is a finger-stick device used to measure blood sugar
Glucometer
This weekly injectable GLP-1 receptor agonist is also approved for weight loss under the brand name Wegovy
Semiglutide/Ozempic
This hormone helps move glucose from the blood into the cells so the body can use it for energy.
Insulin
This type of diabetes can be prevented through diet and exercise
Type 2 Diabetes
This cell in the pancreas produces glucagon
Alpha Cells
This month is nationally recognized as Diabetes Awareness Month.
November
This drug class lowers blood sugar by telling the kidneys to excrete glucose in the urine, and also has proven cardiovascular and kidney-protective benefits.
a) DPP-4 inhibitors
b) SGLT2 inhibitors
c) Alpha-glucosidase inhibitors
d) Sulfonylureas
b) SGLT2 inhibitors
A young patient is diagnosed with diabetes because their pancreas no longer produces insulin due to autoimmune destruction of beta cells.
Type 1 Diabetes
Sleep deprivation has been linked to T2D risk primarily through its effect on this hormone that regulates hunger and insulin sensitivity.
Cortisol / disrupted cortisol and ghrelin regulation
After a meal, excess glucose is converted and stored in this form in the liver and skeletal muscles
Glycogen
This color most commonly represents diabetes awareness, seen on ribbons and the World Diabetes Day Circle
a) red
b) yellow
c) blue
d) purple
c) blue
Metformin's primary mechanism of action involves inhibiting this process in the liver.
a) Glycolysis
b) Glycogenolysis
c) Gluconeogenesis
d) Lipogenesis
C. Gluconeogenesis
This blood test measures a person’s average blood sugar over the past 2–3 months.
Hemoglobin A1c (HbA1c)
This specific dietary pattern, rich in olive oil, legumes, and whole grains, has the strongest evidence for reducing T2D incidence and improving glycemic control.
a) DASH diet
b) Ketogenic diet
c) Low-fat diet
d) Mediterranean diet
d) Mediterranean diet
This glucose transporter is responsible for insulin-stimulated glucose uptake in muscle and fat cells
GLUT4
This nerve complication of diabetes causes numbness/tingling in the feet
Diabetic neuropathy
This dual GIP and GLP-1 receptor agonist was approved by the FDA in 2022 and demonstrated superior A1C reduction and weight loss compared to semaglutide in head-to-head trials.
a) Dulaglutide (Trulicity)
b) Tirzepatide (Mounjaro)
c) Liraglutide (Victoza, Saxenda)
d) Exenatide (Byetta, Bydureon)
b) Tirzepatide (Mounjaro)
A patient with Type 2 diabetes has normal insulin levels, but their cells do not respond effectively to insulin. What is this condition called?
A. Autoimmune beta-cell destruction
B. Insulin resistance
C. Hypoglycemia
D. Glucagon deficiency
B. Insulin resistance
The Diabetes Prevention Program trial showed that intensive lifestyle intervention reduced progression from prediabetes to T2D by approximately this percentage, outperforming metformin alone.
a) 28%
b) 42%
c) 58%
d) 71%
c) 58%
What is the normal fasting blood glucose level?
a) ≤76 mg/dL
b) ≤82 mg/dL
c) ≤99 mg/dL
d) ≤126 mg/dL
c) ≤99 mg/dL
This celebrity has been open about his Type 1 diabetes diagnosis since age 13 and has since become an advocate for diabetes awareness.
a) Nick Jonas
b) Demi Lovato
c) Justin Bieber
d) Selena Gomez
a) Nick Jonas